期刊文献+

人CDK4基因的原核表达及重组蛋白的纯化和复性

Prokaryotic Expression,Purification and Renaturation of Recombinant Human CDK4
下载PDF
导出
摘要 将人CDK4基因克隆入原核表达载体pET28a(+)中,经酶切和测序鉴定正确的重组质粒pET28a-CDK4,转化E.coliBL21(DE3)后获得表达菌株.该表达菌株经IPTG诱导后,高效表达出带有组氨酸标签的以包涵体形式存在的融合蛋白,表达量占菌体总蛋白的52.6%,包涵体经过洗涤、尿素变性溶解、His Trap HP Kit柱纯化、稀释复性,获得纯度达98%以上的蛋白.SDS-PAGE及Western blot分析表明,在分子量34 000处有一特异性蛋白条带.结果表明,已成功的表达和纯化纯度达98%的重组人CDK4蛋白. The expression vector pET28a-CDK4 was constructed by inserting human CDK4 cDNA into pET28a(+) and was identified by digestion with restriction enzymes and sequence analysis. Then an expression strain was selected after transformation of the recombined plasmid into E. coli BL21(DE3), fusion protein with His-tag was efficiently expressed in the form of inclusion body after IPTG induction and its content was approximately 52.6% of total bacteria proteins. The inclusion body was washed, dissolved and purified by Ni^2+ chelate chromatography under denatured condition. The purified inclusion body protein was renatured by the gradual removal of urea via dialysis in solubilization buffer. SDS-PAGE analysis and Western blotting with an anti-CDK4 antibody showed that the fusion protein with a molecular weight of about 43000 was purified and its purity was up to 98%.
出处 《吉林大学学报(理学版)》 CAS CSCD 北大核心 2008年第5期992-996,共5页 Journal of Jilin University:Science Edition
基金 国家自然科学基金(批准号:30671934) 吉林省杰出青年基金(批准号:200600107)
关键词 人CDK4 原核表达 包涵体 融合蛋白 亲和纯化 human CDK4 prokaryotic expression inclusion body fusion protein chelate purification
  • 相关文献

参考文献13

  • 1Sherr C J, Roberts J M. Living with or without Cyclins and Cyclin-dependent Kinases [ J ]. Genes and Development,2004,:18:2699-2711.
  • 2Deshpande A, Sicinski P, Hinds P W. Cyclins and CDKs in Development and Cancer: a Perspective [ J ]. Oncogene, 2005, 24 : 2909-2915.
  • 3Bonin S, Brunetti D, Benedetti E, et al. Expression of Cyclin-dependent Kinases and CDC25a Phosphatase Is Related with Recurrences and Survival in Women with Periand Post-menopausal Breast Cancer [ J ]. Virchows Archiv, 2006, 448(5) : 539-544.
  • 4Reddy H K D L, Mettus R V, Rane S G, et al. Cyclin-dependent Kinase 4 Expression Is Essential for Neu-induced Breast Tumorigenesis [ J]. Cancer Research, 2005, 65 (22) : 10174-10178.
  • 5YU Qun-yan, Sicinska E, Geng Y, et al. Requirement for CDK4 Kinase Function in Breast Cancer [ J ]. Cancer Cell, 2006, 9 ( 1 ) : 23-32.
  • 6Malumbres M, Barbacid M. Is Cyclin D1-CDK4 Kinase a Bona Fide Cancer Target [J]. Cancer Cell, 2006, 9( 1 ) : 2-4.
  • 7DAI Yun, Grant S. Small Molecule Inhibitors Targeting Cyclin-dependent Kinases as Anticancer Agents [ J ]. Current Oncology Reports, 2004, 6(2) : 123-130.
  • 8Fry D W, Bedford D C, Harvey P H, et al. Cell Cycle and Biochemical Effects of PD 0183812: a Potent Inhibitor of Cyclin D-Dependent Kinase CDK4 and CDK6 [ J]. Journal of Biological Chemistry, 2001, 276(20) : 16617-16623.
  • 9Calalb M B, Fox D T, Hanks S K. Molecular Cloning and Enzymatic Analysis of the Rat Homolog of “PhK-yT”, an Isoform of Phosphorylase Kinase Catalytic Subunit [ J]. Journal of Biological Chemistry, 1992, 267 (3) : 1455-1463.
  • 10Lo A S, Zhu Q, Marasco W A. Intraeellular Antibodies (Intrabodies) and Their Theraputie Potential [ J ].. Handbook of Experimental Pharmacology, 2008, 181 : 343-373.

二级参考文献21

  • 1王群,马军,何巍,王晖.定点突变内皮抑素Zn^(2+)的结合位点及突变基因的克隆表达[J].吉林大学学报(理学版),2005,43(1):106-111. 被引量:1
  • 2侯卫红,柴玉荣,王天云,王建民,贾岩龙,薛乐勋.重组人纤溶酶原Kringle1-5的制备及其生物学活性[J].遗传,2005,27(4):617-622. 被引量:3
  • 3[1]Sherr C J. Cancer cell cycles. Science, 1996, 274: 1672~1677
  • 4[2]Buolamwini J K. Cell cycle molecular targets in novel anticancer drug discovery. Curr Pharm Des, 2000,6(4):379~392
  • 5[3]Stillman B. Cell cycle control of DNA replication. Science,1996,274: 1659 ~1664
  • 6[4]Morgan D O. Principles of CDK regulation. Nature,1995,374: 131~134
  • 7[5]Kelland L R. Flavopiridol,the first cyclin-dependent kinase inhibitor to enter the clinic: Current status. Expert Opin Investig Drugs,2000,9(12):2903~2911
  • 8[6]Rao R N. Targets for cancer therapy in the cell cycle pathway. Curr Opin Oncol, 1996,8: 516~524
  • 9[7]Matsushime H, Quelle D E, Shurtleff S A, Shibuya M, Sherr C J, Kato J Y. D-type cyclin-dependent kinase activity in mammalian cells. Mol Cell Biol, 1994, 14(3): 2066~2076
  • 10Murray A W.Recycling the Cell Cycle:Cyclins Revisited[J].Cell,2004,116:221-234.

共引文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部